Table 3.
Characteristics | Total n=211 | Neuroimaging abnormality | P | |
---|---|---|---|---|
With n=63 | Without n=148 | |||
Age (years) | ||||
Mean ± SD | 60.7 ± 15.8 | 56.3 ± 16.1 | 62.6 ± 15.4 | 0.009 |
Gender | ||||
Male | 111 (52.6) | 28 (44.4) | 83 (56.1) | 0.121 |
Female | 100 (47.4) | 35 (55.6) | 65 (43.9) | |
Comorbidities | ||||
Hypertension | 95 (45.0) | 30 (47.6) | 65 (43.9) | 0.621 |
Diabetes | 81 (38.4) | 22 (34.9) | 59 (39.9) | 0.499 |
Heart disease | 51 (24.2) | 13 (20.6) | 38 (25.7) | 0.434 |
COPD | 10 (4.7) | 1 (1.6) | 9 (6.1) | 0.160 |
Chronic kidney disease | 14 (6.6) | 6 (9.5) | 8 (5.4) | 0.271 |
Liver disease | 7 (3.3) | 0 (0.00) | 7 (4.6) | 0.079 |
Malignancy | 18 (8.5) | 4 (6.3) | 14 (9.5) | 0.459 |
Tobacco smoking | 26 (12.3) | 10 (15.9) | 16 (10.8) | 0.306 |
Outcome | ||||
Discharged | 158 (74.9) | 42 (66.7) | 116 (78.4) | 0.073 |
Expired | 53 (25.1) | 21 (33.3) | 32 (21.6) | |
Laboratory findings | ||||
WBC (cells/μL) | 10219±4932 | 11090±5806 | 9849±4480 | 0.094 |
Neutrophil (cells /μL) | 7904 ± 4353 | 9158 ± 5094 | 7371 ± 3894 | 0.006 |
Lymphocyte (cells /μL) | 1586 ± 963 | 1238 ± 714 | 1733 ± 1017 | <0.001 |
Platelet (cells /μL) | 235004±114506 | 247349±105979 | 229750±117901 | 0.308 |
ESR (mm/hr) | 43.0 ± 33.1 | 52.7 ± 27.5 | 39.0 ± 34.3 | <0.001 |
CRP (mg/L) | 37.4 ± 29.0 | 44.3±26.3 | 34.4 ± 29.7 | 0.018 |
CPK (U/L) | 151.1 ± 345.9 | 214.7±592.2 | 121.5 ± 107.3 | 0.235 |
LDH (U/L) | 543.2 ± 436.9 | 518.1±358.0 | 554.0 ± 467.5 | 0.632 |
BUN (mg/dL) | 56.3 ± 49.2 | 50.0±37.3 | 59.0 ± 53.4 | 0.166 |
Creatinine (mg/dL) | 1.5 ± 1.0 | 1.2 ± 0.6 | 1.5 ± 1.1 | 0.027 |
CT lung severity score (0-25) | ||||
Mean ± SD | 7.4 ± 5.3 | 11.1 ± 4.8 | 5.9 ± 4.8 | <0.001 |
Data presented as mean ± standard deviation (SD) or number (%). WBC: White blood cell; CT: computed tomography scan; ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein; CPK: Creatine Phosphokinase; LDH: Lactate dehydrogenase; BUN: Blood urea nitrogen; COPD: Chronic obstructive pulmonary disease.